Is a complete CDNA research report available?

No complete published report is available for CareDx, Inc. (CDNA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CareDx, Inc. (CDNA)

NASDAQ: CDNA · USD

$72.1

+1.62 (+2.3%)· Recorded snapshot

Market cap	3.7B
Revenue (ttm)	458.1M
Net income (ttm)	111M
EPS (ttm)	$2.12
Shares out	51.7M
P/E (trailing)	34.0x
P/E (forward)	67.5x
Volume	778,599
Beta	2.38

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001217234
Company name	CareDx, Inc.
Country	United States
Country code	US
CUSIP number	14167L103
Earnings date	2026-10-29
Earnings time	amc
Employees	765
Employees change	115
Employees growth	17.69%
Enterprise value	$3.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Diagnostics & Research
IPO date	2014-07-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US14167L1035
Last 10-K release date	2026-02-25
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.7B
Market cap category	Mid-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$72.15
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	CDNA
U.S. state	California
Website	https://caredx.com

Metric

Value

Amount currency

USD

CIK code

0001217234

Company name

CareDx, Inc.

Country

United States

Country code

CUSIP number

14167L103

Earnings date

2026-10-29

Earnings time

amc

Employees

765

Employees change

115

Employees growth

17.69%

Enterprise value

$3.4B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

In index

RUSSELL2000

Industry

Diagnostics & Research

IPO date

2014-07-17

Is primary listing

Yes

Is SPAC

ISIN number

US14167L1035

Last 10-K release date

2026-02-25

Last earnings date

2026-07-30

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$3.7B

Market cap category

Mid-Cap

Next earnings date

2026-10-29

Options

Yes

Price

$72.15

Price currency

USD

Sector

Healthcare

SIC code

8071

Stock price date

2026-10-28

Symbol

CDNA

U.S. state

California

Website

https://caredx.com

Metric	Value
Adjusted P/E ratio	65x
Earnings yield	2.94%
EV/Earnings	30.63x
EV/EBITDA	273.46x
EV/FCF	40.14x
EV/Sales	7.42x
FCF / EV yield	2.49%
FCF yield	2.26%
Forward EV/Sales	6.81x
Forward P/E	67.46x
Forward P/S	7.52x
Graham number	19.85858
Graham upside	-72.64%
Industry forward P/E	30.87x
Industry P/E	50.24x
P/(FCF - SBC) ratio	78.64x
P/(OCF - SBC) ratio	66.22x
P/B ratio	8.53x
P/E ratio	34.03x
P/FCF ratio	44.32x
P/OCF ratio	40.09x
P/S ratio	8.2x
Price / tangible book value	10.12x
Price/EBITDA ratio	301.97x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

65x

Earnings yield

2.94%

EV/Earnings

30.63x

EV/EBITDA

273.46x

EV/FCF

40.14x

EV/Sales

7.42x

FCF / EV yield

2.49%

FCF yield

2.26%

Forward EV/Sales

6.81x

Forward P/E

67.46x

Forward P/S

7.52x

Graham number

19.85858

Graham upside

-72.64%

Industry forward P/E

30.87x

Industry P/E

50.24x

P/(FCF - SBC) ratio

78.64x

P/(OCF - SBC) ratio

66.22x

P/B ratio

8.53x

P/E ratio

34.03x

P/FCF ratio

44.32x

P/OCF ratio

40.09x

P/S ratio

8.2x

Price / tangible book value

10.12x

Price/EBITDA ratio

301.97x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-0.43%
EBITDA margin	2.71%
Effective tax rate	3.63%
FCF margin	18.49%
Gross margin	70.58%
Operating margin	-0.43%
Pretax margin	25.15%
Profit margin	24.23%
Profit per employee	$145,114
Profitable quarters	2
Revenue per employee	$598,809
ROA	-0.25%
ROA (5Y)	-7.27%
ROCE	-0.45%
ROE	29.49%
ROE (5Y)	-14.03%
ROIC	-1.71%
ROIC (5Y)	-47.3%
SBC / revenue	8.07%
Tax / revenue	0.91%

Metric

Value

EBIT margin

-0.43%

EBITDA margin

2.71%

Effective tax rate

3.63%

FCF margin

18.49%

Gross margin

70.58%

Operating margin

-0.43%

Pretax margin

25.15%

Profit margin

24.23%

Profit per employee

$145,114

Profitable quarters

Revenue per employee

$598,809

ROA

-0.25%

ROA (5Y)

-7.27%

ROCE

-0.45%

ROE

29.49%

ROE (5Y)

-14.03%

ROIC

-1.71%

ROIC (5Y)

-47.3%

SBC / revenue

8.07%

Tax / revenue

0.91%

Metric	Value
EPS growth	112.54%
EPS growth (QoQ)	4,040.08%
EPS growth quarters	2
EPS growth years	0
FCF growth	613.13%
FCF growth (Q)	223.43%
FCF growth (QoQ)	5,492.61%
Gross profit growth	41.82%
Gross profit growth (Q)	67.15%
Gross profit growth 3Y	17.43%
Gross profit growth 5Y	13.41%
Net income growth	90.94%
Net income growth (QoQ)	3,838.63%
Net income growth quarters	2
Net income growth years	0
OCF growth	428.48%
OCF growth (Q)	209.29%
OCF growth (QoQ)	606.3%
OCF growth 3Y	595.83%
Revenue growth	34.41%
Revenue growth (Q)	52.23%
Revenue growth (QoQ)	12.11%
Revenue growth 10Y	30.86%
Revenue growth 3Y	13.99%
Revenue growth 5Y	12.55%
Revenue growth quarters	4
Revenue growth years	2

Metric

Value

EPS growth

112.54%

EPS growth (QoQ)

4,040.08%

EPS growth quarters

EPS growth years

FCF growth

613.13%

FCF growth (Q)

223.43%

FCF growth (QoQ)

5,492.61%

Gross profit growth

41.82%

Gross profit growth (Q)

67.15%

Gross profit growth 3Y

17.43%

Gross profit growth 5Y

13.41%

Net income growth

90.94%

Net income growth (QoQ)

3,838.63%

Net income growth quarters

Net income growth years

OCF growth

428.48%

OCF growth (Q)

209.29%

OCF growth (QoQ)

606.3%

OCF growth 3Y

595.83%

Revenue growth

34.41%

Revenue growth (Q)

52.23%

Revenue growth (QoQ)

12.11%

Revenue growth 10Y

30.86%

Revenue growth 3Y

13.99%

Revenue growth 5Y

12.55%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-9M
Depreciation and amortization	$14.4M
EBIT	$-2M
EBITDA	$12.4M
EPS	$2.12
FCF per share	$1.64
Financing cash flow	$-57.3M
Free cash flow	$84.7M
Free cash flow minus SBC	$47.7M
Gross profit	$323.3M
Income taxes	$4.2M
Investing cash flow	$269.1M
Net cash flow	$305.4M
Net income	$111M
Operating cash flow minus SBC	$56.7M
Operating income	$-2M
Revenue	$458.1M
Stock-based compensation	$37M

Metric

Value

Capital expenditures

$-9M

Depreciation and amortization

$14.4M

EBIT

$-2M

EBITDA

$12.4M

EPS

$2.12

FCF per share

$1.64

Financing cash flow

$-57.3M

Free cash flow

$84.7M

Free cash flow minus SBC

$47.7M

Gross profit

$323.3M

Income taxes

$4.2M

Investing cash flow

$269.1M

Net cash flow

$305.4M

Net income

$111M

Operating cash flow minus SBC

$56.7M

Operating income

$-2M

Revenue

$458.1M

Stock-based compensation

$37M

Metric	Value
Altman Z-Score	5.49
Book value per share	$8.27
Debt / EBITDA	0.97
Debt / equity	0.05
Debt / FCF	0.23
Goodwill	$36M
Long-term assets	$103.8M
Long-term liabilities	$13.7M
Net cash (debt)	$354.4M
Net cash / market cap	9.44%
Net cash growth	125.53%
Net debt / EBITDA	-28.5
Net debt / equity	-0.83
Net debt / FCF	-4.18
Piotroski F-Score	5
Property, plant and equipment	$43M
Shareholders' equity	$425.6M
Tangible book value	$371.1M
Tangible book value per share	$7.21
Total assets	$533M
Total cash	$373.6M
Total debt	$19.2M
Total liabilities	$107.4M
WACC	17.27%

Metric

Value

Altman Z-Score

5.49

Book value per share

$8.27

Debt / EBITDA

0.97

Debt / equity

0.05

Debt / FCF

0.23

Goodwill

$36M

Long-term assets

$103.8M

Long-term liabilities

$13.7M

Net cash (debt)

$354.4M

Net cash / market cap

9.44%

Net cash growth

125.53%

Net debt / EBITDA

-28.5

Net debt / equity

-0.83

Net debt / FCF

-4.18

Piotroski F-Score

Property, plant and equipment

$43M

Shareholders' equity

$425.6M

Tangible book value

$371.1M

Tangible book value per share

$7.21

Total assets

$533M

Total cash

$373.6M

Total debt

$19.2M

Total liabilities

$107.4M

WACC

17.27%

Metric	Value
Asset turnover	0.94
Current assets	$429.2M
Current liabilities	$93.7M
Current ratio	4.58
Inventory turnover	7.72
Net working capital	$-32.1M
Quick ratio	4.35
Working capital	$335.5M
Working capital turnover	1.67

Metric

Value

Asset turnover

0.94

Current assets

$429.2M

Current liabilities

$93.7M

Current ratio

4.58

Inventory turnover

7.72

Net working capital

$-32.1M

Quick ratio

4.35

Working capital

$335.5M

Working capital turnover

1.67

Metric	Value
Buyback yield / dilution	9.45%
Dividend yield	0%
Shareholder yield	9.45%

Metric

Value

Buyback yield / dilution

9.45%

Dividend yield

Shareholder yield

9.45%

Metric	Value
10Y price change	1,784.68%
10Y return CAGR	34.14%
10Y total return	1,784.68%
150-day SMA	$37.70
1D price change	2.29%
1M price change	13.95%
1M total return	13.95%
1W price change	4.86%
1W total return	4.86%
1Y price change	400.07%
1Y return CAGR	400.62%
1Y total return	400.07%
20-day SMA	$66.87
200-day SMA	$33.05
3M price change	99.56%
3M total return	99.56%
3Y price change	1,351.2%
3Y return CAGR	143.87%
3Y total return	1,351.2%
50-day SMA	$58.63
50-day SMA vs 200-day SMA	50over200
52-week high	$73.43
52-week high date	2026-10-28
52-week low	$14.23
52-week low date	2025-10-30
5Y price change	7.64%
5Y return CAGR	1.48%
5Y total return	7.64%
6M price change	232.08%
6M total return	232.08%
All-time high	$99.83
All-time high date	2021-01-20
All-time low	$0.76
All-time low date	2017-04-28
Average true range (ATR)	$3.84
Average volume	1.3M
Beta (1Y)	0.6
Beta (2Y)	0.92
Beta (5Y)	2.38
Change from 52-week high	-1.75%
Change from 52-week low	407.17%
Change from all-time high	-27.32%
Change from all-time low	9,447.37%
Change from open	2.68%
Day's gap	-0.38%
Dollar volume	$56.2M
High price	$73.31
Low price	$70.26
Monthly RSI	84.1
Open price	$70.26
Position in 52-week range	61.8%
Premarket change	-1.74%
Premarket close	$70.53
Premarket price	$69.30
Premarket volume	1.3K
Previous close	$70.53
Price vs 150-day SMA	92.46%
Price vs 20-day SMA	8.51%
Price vs 200-day SMA	119.54%
Price vs 50-day SMA	23.76%
Relative volume	0.59
RSI	69.35
Sharpe ratio	2.5
Sharpe ratio (3Y)	1.48
Sharpe ratio (5Y)	0.35
Sortino ratio	5.79
Sortino ratio (3Y)	2.5
Sortino ratio (5Y)	0.59
Volume	778.6K
Weekly RSI	84.82
YTD price change	285.14%
YTD total return	285.14%

Metric

Value

10Y price change

1,784.68%

10Y return CAGR

34.14%

10Y total return

1,784.68%

150-day SMA

$37.70

1D price change

2.29%

1M price change

13.95%

1M total return

13.95%

1W price change

4.86%

1W total return

4.86%

1Y price change

400.07%

1Y return CAGR

400.62%

1Y total return

400.07%

20-day SMA

$66.87

200-day SMA

$33.05

3M price change

99.56%

3M total return

99.56%

3Y price change

1,351.2%

3Y return CAGR

143.87%

3Y total return

1,351.2%

50-day SMA

$58.63

50-day SMA vs 200-day SMA

50over200

52-week high

$73.43

52-week high date

2026-10-28

52-week low

$14.23

52-week low date

2025-10-30

5Y price change

7.64%

5Y return CAGR

1.48%

5Y total return

7.64%

6M price change

232.08%

6M total return

232.08%

All-time high

$99.83

All-time high date

2021-01-20

All-time low

$0.76

All-time low date

2017-04-28

Average true range (ATR)

$3.84

Average volume

1.3M

Beta (1Y)

0.6

Beta (2Y)

0.92

Beta (5Y)

2.38

Change from 52-week high

-1.75%

Change from 52-week low

407.17%

Change from all-time high

-27.32%

Change from all-time low

9,447.37%

Change from open

2.68%

Day's gap

-0.38%

Dollar volume

$56.2M

High price

$73.31

Low price

$70.26

Monthly RSI

84.1

Open price

$70.26

Position in 52-week range

61.8%

Premarket change

-1.74%

Premarket close

$70.53

Premarket price

$69.30

Premarket volume

1.3K

Previous close

$70.53

Price vs 150-day SMA

92.46%

Price vs 20-day SMA

8.51%

Price vs 200-day SMA

119.54%

Price vs 50-day SMA

23.76%

Relative volume

0.59

RSI

69.35

Sharpe ratio

2.5

Sharpe ratio (3Y)

1.48

Sharpe ratio (5Y)

0.35

Sortino ratio

5.79

Sortino ratio (3Y)

2.5

Sortino ratio (5Y)

0.59

Volume

778.6K

Weekly RSI

84.82

YTD price change

285.14%

YTD total return

285.14%

Metric	Value
Float	49.5M
Float percentage	95.6%
Shares change (QoQ)	-3.13%
Shares change (YoY)	-9.45%
Shares held by insiders	4.4%
Shares held by institutions	101.73%
Shares outstanding	51.7M
Short % of float	13.58%
Short % of shares	12.98%
Short ratio	5.2 days

Metric

Value

Float

49.5M

Float percentage

95.6%

Shares change (QoQ)

-3.13%

Shares change (YoY)

-9.45%

Shares held by insiders

4.4%

Shares held by institutions

101.73%

Shares outstanding

51.7M

Short % of float

13.58%

Short % of shares

12.98%

Short ratio

5.2 days

CareDx, Inc. (CDNA)

Price

Financial snapshot

Fair-value bridge

Latest news · CDNA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CDNA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CDNA

Frequently asked questions